Skip to search formSkip to main contentSkip to account menu

L-165041

Known as: L 165041 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
The PPARβ agonist L-165041 promotes VEGF mRNA stabilization in HPV18-harboring HeLa cells through a receptor-independent mechanism.
2013
2013
Bioactivity screening and mass spectrometric confirmation for the detection of PPARδ agonists that increase type 1 muscle fibres
Sensitive and robust bioassays able to detect nuclear receptor activation are very useful for veterinary and doping control… 
2012
2012
The PPARδ ligand L‐165041 inhibits vegf‐induced angiogenesis, but the antiangiogenic effect is not related to PPARδ
Peroxisome proliferator‐activated receptor (PPAR)δ is known to be expressed ubiquitously and involved in lipid and glucose… 
2011
2011
Pharmacological Activation of Peroxisome Proliferator-activated Receptor δ Improves Insulin Resistance and Hepatic Steatosis in High Fat Diet-induced Diabetic Mice
Abstract The mechanisms regarding hepatic steatosis related to hepatic insulin resistance have been well documented. However, the… 
Highly Cited
2010
Highly Cited
2010
Endothelium-Dependent Vasodilator Effects of Peroxisome Proliferator-Activated Receptor β Agonists via the Phosphatidyl-Inositol-3 Kinase-Akt Pathway
Peroxisome proliferator-activated receptor β/δ (PPAR-β) is a ligand-activated transcription factor belonging to the nuclear… 
2006
2006
Neuroprotective Efficacy of the Peroxisome Proliferator-Activated Receptor delta (PPAR-δ) Selective Agonists, L-165041 and GW501516, in Vitro and in Vivo
2005
2005
Peroxisome proliferator-activated receptor delta as a molecular target to regulate lung cancer cell growth.
It has been assumed that prostaglandin (PG)I2 signaling contributes to the negative growth control of lung cancer cells; however… 
2002
2002
Pharmacological analysis of wild-type α, γ and δ subtypes of the human peroxisome proliferator-activated receptor
Abstract. Three distinct peroxisome proliferator-activated receptor (PPAR) cDNAs were isolated from human brain RNA. Whereas the… 
2002
2002
Pharmacological analysis of wild-type alpha, gamma and delta subtypes of the human peroxisome proliferator-activated receptor.
Three distinct peroxisome proliferator-activated receptor (PPAR) cDNAs were isolated from human brain RNA. Whereas the PPARdelta… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)